Atomwise
Harnessing the power of AI, this platform revolutionizes drug discovery by integrating machine learning with vast chemical libraries. Its innovative engine employs convol... Harnessing the power of AI, this platform revolutionizes drug discovery by integrating machine learning with vast chemical libraries. Its innovative engine employs convolutional neural networks to efficiently explore trillions of compounds, increasing the probability of identifying effective small-molecule medicines. The focus remains on tackling challenging targets to enhance drug developers' success rates.
Top Atomwise Alternatives
SCIEX
This drug discovery software seamlessly integrates with high-performance LC-MS/MS systems, enhancing data acquisition and analysis for precise molecular detection. With...
Recursion
Leveraging proprietary biological, chemical, and real-world patient data, this advanced biotechnology company utilizes a supercomputer, BioHive-2, to scale up drug...
Phoenix PK/PD Platform
The Phoenix™ PK/PD Platform equips scientists with advanced tools for pharmacokinetic and pharmacodynamic modeling, facilitating robust analysis from preclinical to...
DNAnexus Apollo
DNAnexus Apollo™ revolutionizes precision drug discovery by integrating multimodal data, analytics, and collaboration tools in a secure cloud platform. It...
Schrödinger
Transforming drug discovery and materials research, Schrödinger's advanced molecular modeling platform leverages physics-driven computational solutions for predictive modeling and data...
Chemical Computing Group
Offering advanced tools for 3D molecular visualization, Chemical Computing Group empowers researchers in structure-based and ligand-based design, antibody development, and...
LiveDesign
LiveDesign offers a flexible, cloud-native environment for discovery teams, facilitating small and large molecule research. It streamlines workflows through centralized...
Genedata Imagence
Genedata Imagence revolutionizes high-content screening analysis by enabling biologists to harness deep learning for cellular phenotype classification in imaging data....
NoviSight 3D
NoviSight 3D cell analysis software enhances research by delivering precise statistical data on spheroids and other three-dimensional structures in microplate...
Genedata Biologics
Streamlining biotherapeutic discovery, this industry-leading software supports the development of bispecifics, ADCs, TCRs, CAR-Ts, and AAVs. By integrating all R&D...
Impurity Profiling Suite
The Impurity Profiling Suite efficiently predicts toxicological endpoints for impurities and degradants, ensuring compliance with ICH M7 guidelines. Developed in...
Healnet
Healnet revolutionizes drug discovery by leveraging AI to analyze extensive drug and disease data, uncovering novel treatment connections for rare...
ADME Suite
The ADME Suite is an advanced drug discovery software that streamlines the prediction of absorption, distribution, metabolism, and excretion (ADME)...
FCS Express
FCS Express™ seamlessly transforms raw flow cytometry data into clear, presentation-ready results with remarkable efficiency. Designed for researchers familiar with...
Katalyst D2D
Katalyst D2D is a cutting-edge drug discovery software that streamlines high-throughput experimentation through integrated automation for planning, executing, and analyzing...
Company Information
- Company: Atomwise
- Country: United States
Top Atomwise Features
- AI-driven drug discovery
- Convolutional neural networks integration
- Massive chemical library access
- High computational efficiency
- Screening of trillions of compounds
- Enhanced model accuracy
- Reduced false positive rates
- Wholly owned pipeline assets
- Co-developed pipeline collaborations
- Rapid medicine development process
- Transformative small molecule discovery
- User-friendly AI platform
- Focus on challenging drug targets
- Backed by prominent investors
- Scalable discovery solutions
- Continuous improvement of algorithms
- Real-time data analysis
- Customizable discovery workflows
- Robust predictive analytics
- Accelerated clinical trial readiness.